Jin-Shing Chen Selected Research

Pleurodesis

3/2019	Evaluation of pleurodesis by poly-ε-caprolactone (PCL) gel in an animal model using New Zealand white rabbits.
11/2017	Study of poly-ɛ-caprolactone membranes for pleurodesis.
7/2014	Intrapleural minocycline pleurodesis for the treatment of primary spontaneous pneumothorax.
5/2014	Chemical pleurodesis for prolonged postoperative air leak in primary spontaneous pneumothorax.
12/2013	Chemical pleurodesis for spontaneous pneumothorax.
7/2013	Pleurodesis for primary spontaneous pneumothorax - authors' reply.
4/2013	Video-assisted thoracoscopic surgery for recurrent pneumothorax in pulmonary lymphangioleimyomatosis with tuberous sclerosis complex.
4/2013	Simple aspiration and drainage and intrapleural minocycline pleurodesis versus simple aspiration and drainage for the initial treatment of primary spontaneous pneumothorax: an open-label, parallel-group, prospective, randomised, controlled trial.
3/2012	Thoracoscopic pleurodesis for primary spontaneous pneumothorax with high recurrence risk: a prospective randomized trial.
6/2008	Patterns, effects, and thoracic volume changes of thoracoscopic pleurodesis in rabbits.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin-Shing Chen Research Topics

Disease

47	Neoplasms (Cancer) 08/2022 - 06/2003
23	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2004
22	Pneumothorax 11/2021 - 01/2004
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2022 - 12/2011
7	Neoplasm Metastasis (Metastasis) 08/2022 - 06/2003
7	Hemorrhage 09/2017 - 12/2011
6	Adenocarcinoma of Lung 01/2022 - 10/2015
6	Infections 12/2017 - 07/2007
5	Thymoma (Thymic Carcinoma) 01/2022 - 01/2014
5	Blister (Bulla) 12/2016 - 01/2004
5	Hypoxia (Hypoxemia) 01/2014 - 05/2009
5	Esophageal Neoplasms (Esophageal Cancer) 02/2013 - 01/2005
4	Empyema 01/2020 - 12/2003
4	Pulmonary Hypertension 09/2017 - 05/2007
4	Chest Pain (Chest Pains) 03/2012 - 01/2004
3	Pain (Aches) 01/2020 - 12/2011
2	Cough 01/2022 - 01/2014
2	Respiratory Sounds (Crackle) 01/2021 - 02/2019
2	Pulmonary Atelectasis 02/2019 - 01/2014
2	Postoperative Pain 01/2018 - 04/2003
2	Fever (Fevers) 01/2017 - 12/2003
2	Wounds and Injuries (Trauma) 10/2016 - 02/2014
2	Tachypnea 01/2014 - 08/2012
2	Pulmonary Arterial Hypertension 05/2009 - 02/2008
2	Familial Primary Pulmonary Hypertension 07/2007 - 01/2005
2	Carcinogenesis 01/2005 - 06/2003
2	Breast Neoplasms (Breast Cancer) 06/2004 - 06/2003
1	COVID-19 01/2022
1	Vomiting 01/2022
1	Malaria 01/2022
1	Tissue Adhesions 01/2021
1	Rupture 01/2021

Drug/Important Bio-Agent (IBA)

12	ErbB Receptors (EGF Receptor)IBA 08/2022 - 07/2011
7	Tyrosine Kinase InhibitorsIBA 08/2022 - 07/2015
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
6	Anesthetics (Anesthetic Agents)IBA 07/2020 - 01/2014
6	Minocycline (Cyclops)FDA LinkGeneric 07/2014 - 01/2004
5	Carcinoembryonic AntigenIBA 03/2022 - 10/2014
4	RNA (Ribonucleic Acid)IBA 10/2017 - 01/2016
3	Coloring Agents (Dyes)IBA 01/2019 - 10/2016
3	MicroRNAs (MicroRNA)IBA 01/2017 - 09/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2016 - 12/2003
3	Analgesics (Analgesic Drugs)IBA 12/2014 - 01/2004
3	Meperidine (Pethidine)FDA LinkGeneric 03/2012 - 04/2003
2	xylometazoline (stas)IBA 01/2022 - 12/2018
2	Oxygen (Dioxygen)IBA 09/2020 - 09/2017
2	Biocompatible Materials (Biomaterials)IBA 03/2019 - 11/2017
2	AfatinibIBA 01/2019 - 01/2017
2	sulfan blue (patent blue V)IBA 01/2019 - 10/2016
2	Gefitinib (Iressa)FDA Link 01/2019 - 01/2017
2	CytokinesIBA 12/2017 - 04/2010
2	Codon (Codons)IBA 05/2016 - 02/2006
2	Biomarkers (Surrogate Marker)IBA 12/2014 - 06/2004
2	SurvivinIBA 04/2011 - 11/2004
2	Simvastatin (Zocor)FDA LinkGeneric 03/2011 - 05/2009
2	MonocrotalineIBA 03/2011 - 05/2009
2	Biological ProductsIBA 06/2004 - 06/2003
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	osimertinibIBA 01/2022
1	Antimalarials (Antimalarial Agents)IBA 01/2022
1	tafenoquineIBA 01/2022
1	PlatinumIBA 01/2022
1	exodeoxyribonuclease IIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2021
1	Polyglactin 910IBA 11/2021
1	CatalaseIBA 01/2021
1	AlginatesIBA 01/2021
1	catechol (pyrocatechol)IBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	HydrogelsIBA 01/2021
1	Propofol (Diprivan)FDA LinkGeneric 09/2020

Therapy/Procedure

13	Therapeutics 08/2022 - 06/2003
13	Segmental Mastectomy (Lumpectomy) 01/2022 - 10/2013
12	Length of Stay 01/2020 - 04/2003
12	Pleurodesis 03/2019 - 01/2004
11	Chest Tubes (Chest Tube) 09/2017 - 12/2003
8	One-Lung Ventilation 09/2020 - 12/2011
7	Epidural Anesthesia 01/2022 - 12/2011
7	General Anesthesia 01/2022 - 12/2011
7	Thoracotomy 09/2017 - 03/2006
5	Anesthesia 02/2020 - 04/2010
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
3	Pneumonectomy (Lung Volume Reduction) 10/2016 - 04/2013
3	Debridement 10/2016 - 12/2003
3	Extracorporeal Membrane Oxygenation 01/2012 - 02/2008
3	Esophagectomy 07/2011 - 01/2005
2	Radiotherapy 12/2021 - 04/2013
2	Minimally Invasive Surgical Procedures 01/2021 - 12/2017
2	Injections 01/2021 - 03/2012
2	Analgesia 02/2019 - 03/2013
2	Operative Time 01/2018 - 04/2010
2	Thymectomy 01/2018 - 01/2014
2	Thoracostomy 01/2017 - 01/2012
2	Catheters 01/2017 - 04/2013
2	Lung Transplantation 04/2009 - 01/2009
2	Transplantation 01/2009 - 02/2008
1	Personal Protective Equipment 01/2022
1	Perioperative Period 01/2022
1	Stethoscopes 01/2021
1	Nerve Block (Nerve Blocks) 09/2020